Currently, SILO Pharma Inc [SILO] is trading at $0.45, up 4.17%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The SILO shares have gain 13.95% over the last week, with a monthly amount drifted -17.94%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
This stock has fluctuated between a low of $0.36 and a high of $3.37 over the last 52 weeks. SILO Pharma Inc [NASDAQ: SILO] shares were valued at $0.45 at the most recent close of the market.
Analyzing the SILO fundamentals
Gross Profit Margin for this corporation currently stands at 0.65% with Operating Profit Margin at -73.61%, Pretax Profit Margin comes in at -70.41%, and Net Profit Margin reading is -70.41%. To continue investigating profitability, this company’s Return on Assets is posted at -23.04, Equity is -1.07 and Total Capital is 10.88.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4237 points at the first support level, and at 0.3972 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4730, and for the 2nd resistance point, it is at 0.4958.
Ratios To Look Out For
To put it in perspective, the Current Ratio for SILO Pharma Inc [NASDAQ:SILO] is 8.70. Also, the Quick Ratio is 8.70, while the Cash Ratio stands at 5.53. Considering the valuation of this stock, the price to sales ratio is 85.56, the price to book ratio is 0.94.
Transactions by insiders
Recent insider trading involved Weisblum Eric, Chief Executive Officer, that happened on Nov 20 ’25 when 1000.0 shares were purchased. Chief Executive Officer, Weisblum Eric completed a deal on Nov 21 ’25 to buy 1000.0 shares. Meanwhile, Chief Executive Officer Weisblum Eric bought 7500.0 shares on Nov 18 ’25.
